Transurethral resection versus transurethral incision of the prostate: a subjective and objective analysis

To assess and compare the outcome and complications of transurethral prostatectomy [TURP] versus transurethral incision of the prostate [TUIP] in patients having bladder outlet obstruction. Fifty patients suffering form benign prostatic hyperplasia [BPH] with prostate size of <30 gms were included in this study. Group a [25 patients] underwent TURP while in group B [25 patients] TUIP was performed. The patients were assessed using International Prostatic Symptoms Scoring System [IPSS], uroflownetry, TRUS and postvoid residual urine volume. Follow up was done at 1,3,6 and 9 months intervals. There was no statistically significant difference in the mean age among the two groups. IPSS score dropped by 81.55% for group A and 85.71% for group B at 9 months postoperatively from baseline. The overall improvement in maximum flow rates as recorded for both groups was 172.60% and 249% respectively while it was 182.8% and 279% for group A and B in average flow rates. The mean drop in postvoid residual urine volume for group A was -88.50% and -99.02% for group B. Overall 84% of patients in group A and 92% of patients in group B were well satisfied with the outcome of procedures. TUIP is an effective and comparable treatment modality for BPH with gland size of < 30 grams. Results of TURP and TUIP were comparable, but TUIP was simple and easier to perform, with less morbidity and shorter operation time than TURP

Complete androgen blockade in advanced prostate cancer: a clinical experience

To evaluate the clinical and biochemical outcome of patients with advanced prostate cancer treated by complete androgen blockage [CAB]. A total number of thirty patients with histologically confirmed advance prostate cancer and serum PSA level of more than 30ng/ml were subjected to bilateral subcapsular orchidectomy, supplemented with oral antiandrogens. These patients were followed for a period of two years by recording their symptoms and serum PSA level at twelve weeks intervals. Only 16[53.33%] patients complied with the protocol of the study and observed two years followup. 12[75%] patients showed complete response to CAB while 4[25%] patients showed rising PSA levels and became symptomatic after one year of treatment. CAB is still the treatment of choice for patients with advanced prostate cancer

Chemical dissolultion of urinary uric acid stones by the use of citro soda

The objective of this study was to find out the role of citrosoda sachet in the chemical dissolution of Urinary uric acid stones. This study was conducted from Aug 2000 to Aug: 2002. All patients with urinary uric acid stones were included in the study. Citro soda was used as one sachet in half glass of cold water three times a day for ten to sixty days. All the patients were regularly followed up and pH of the urine was checked regularly in follow-up clinic. Total number of patients were 30. Out of these 20 were male [67%] and 10 [33%] were female. Age range was from 15-50 years; average 32.5 years. Size of stone was ranging from 9 mm to 2.4 cm.Out of 30 cases 22 [73%] were kidney stones and 8 [27%] were Ureteric Stones. Out of 30 stones 28 [93%] were completely dissolved and two were partially dissolved. Duration of treatment was 10 days to 2 months. The partially dissolved stones were managed by ESWL. Twenty Eight out of Thirty stones were completely dissolved and two partially which were managed by ESWL making 93.4% and 6.6% respectively. This Study concludes that Urinary Uric acid stones can be dissolved by the use of citrosoda sachet and can also be prevented by the use of this sachet